» Articles » PMID: 30323274

Diverse Definitions of the Early Course of Schizophrenia-a Targeted Literature Review

Overview
Journal NPJ Schizophr
Date 2018 Oct 17
PMID 30323274
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Schizophrenia is a debilitating psychiatric disorder and patients experience significant comorbidity, especially cognitive and psychosocial deficits, already at the onset of disease. Previous research suggests that treatment during the earlier stages of disease reduces disease burden, and that a longer time of untreated psychosis has a negative impact on treatment outcomes. A targeted literature review was conducted to gain insight into the definitions currently used to describe patients with a recent diagnosis of schizophrenia in the early course of disease ('early' schizophrenia). A total of 483 relevant English-language publications of clinical guidelines and studies were identified for inclusion after searches of MEDLINE, MEDLINE In-Process, relevant clinical trial databases and Google for records published between January 2005 and October 2015. The extracted data revealed a wide variety of terminology and definitions used to describe patients with 'early' or 'recent-onset' schizophrenia, with no apparent consensus. The most commonly used criteria to define patients with early schizophrenia included experience of their first episode of schizophrenia or disease duration of less than 1, 2 or 5 years. These varied definitions likely result in substantial disparities of patient populations between studies and variable population heterogeneity. Better agreement on the definition of early schizophrenia could aid interpretation and comparison of studies in this patient population and consensus on definitions should allow for better identification and management of schizophrenia patients in the early course of their disease.

Citing Articles

Along-tract white matter abnormalities and their clinical associations in recent-onset and chronic schizophrenia.

Joo S, Park H, Park J, Lee J Schizophrenia (Heidelb). 2025; 11(1):37.

PMID: 40050653 PMC: 11885433. DOI: 10.1038/s41537-025-00586-1.


Prefrontal Oscillatory Slowing in Early-Course Schizophrenia Is Associated With Worse Cognitive Performance and Negative Symptoms: A Transcranial Magnetic Stimulation-Electroencephalography Study.

Donati F, Mayeli A, Nascimento Couto B, Sharma K, Janssen S, Krafty R Biol Psychiatry Cogn Neurosci Neuroimaging. 2024; 10(2):158-166.

PMID: 39059465 PMC: 11759720. DOI: 10.1016/j.bpsc.2024.07.013.


Long-term safety and effectiveness of lurasidone in adolescents and young adults with schizophrenia: pooled post hoc analyses of two 12-month extension studies.

Calisti F, Tocco M, Mao Y, Goldman R Ann Gen Psychiatry. 2024; 23(1):26.

PMID: 39020362 PMC: 11256627. DOI: 10.1186/s12991-024-00502-4.


Hippocampal Network Dysfunction in Early Psychosis: A 2-Year Longitudinal Study.

Avery S, Rogers B, McHugo M, Armstrong K, Blackford J, Vandekar S Biol Psychiatry Glob Open Sci. 2023; 3(4):979-989.

PMID: 37881573 PMC: 10593896. DOI: 10.1016/j.bpsgos.2022.10.002.


Predictors of treatment discontinuation during an 18-month multi-site randomized trial of Cognitive Enhancement Therapy for early course schizophrenia.

Wojtalik J, Brown W, Mesholam-Gately R, Kotwani A, Keshavan M, Eack S Psychiatry Res. 2023; 326:115254.

PMID: 37267670 PMC: 10527356. DOI: 10.1016/j.psychres.2023.115254.


References
1.
Perkins D, Gu H, Boteva K, Lieberman J . Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry. 2005; 162(10):1785-804. DOI: 10.1176/appi.ajp.162.10.1785. View

2.
Bernier D, Cookey J, McAllindon D, Bartha R, Hanstock C, Newman A . Multimodal neuroimaging of frontal white matter microstructure in early phase schizophrenia: the impact of early adolescent cannabis use. BMC Psychiatry. 2013; 13:264. PMC: 3852698. DOI: 10.1186/1471-244X-13-264. View

3.
Egerton A, Brugger S, Raffin M, Barker G, Lythgoe D, McGuire P . Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia. Neuropsychopharmacology. 2012; 37(11):2515-21. PMC: 3442346. DOI: 10.1038/npp.2012.113. View

4.
Tikka S, Garg S, Sinha V, Nizamie S, Goyal N . Resting State Dense Array Gamma Oscillatory Activity as a Response Marker for Cerebellar-Repetitive Transcranial Magnetic Stimulation (rTMS) in Schizophrenia. J ECT. 2015; 31(4):258-62. DOI: 10.1097/YCT.0000000000000242. View

5.
Zhang F, Qiu L, Yuan L, Ma H, Ye R, Yu F . Evidence for progressive brain abnormalities in early schizophrenia: a cross-sectional structural and functional connectivity study. Schizophr Res. 2014; 159(1):31-5. DOI: 10.1016/j.schres.2014.07.050. View